Today is the first National PrEP Day — a new annual event dedicated to spreading information and awareness around HIV ...

Oct. 10, 2025, is officially the first-ever National PrEP Day, and MISTR and SISTR are going big. Their goal? Get 10,000 new ...

Earlier this year, we wrote about PrEP (pre-exposure prophylaxis), a drug that prevents people from getting the HIV virus -- but which, after a decade, still needs to make more headway in the gay ...

Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...

A data analysis found a 22% reduction in HIV pre-exposure prophylaxis (PrEP) prescriptions and a 25% reduction in new PrEP users in the United States after COVID-19 was declared a national emergency.

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo (lenacapavir), a new era of HIV prevention has dawned. The approval, which ...

Please provide your email address to receive an email when new articles are posted on . More than 40 years ago, on June 5, 1981, a report of five cases of Pneumocystis pneumonia among young men in Los ...

Sustaining the achievements of the past two decades of global HIV programs and reaching the goal of ending HIV/AIDS as a public health threat by 2030 depend on dramatically reducing new infections.